Experimental cancer drug offered outside trials for desperate patients
NCT ID NCT03756311
Summary
This program offered an investigational cancer drug called NanoPac to patients with advanced pancreatic, prostate, or lung cancer who could not join the main clinical trials. It was a way for people who did not meet the strict trial requirements to potentially try the treatment. The program is no longer available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.